The consensus price target for Crown Holdings, Inc. (NYSE:CCK) has been adjusted from $116.5 to $110, indicating a conservative outlook from analysts.Despite a predicted decline in earnings, Crown Holdings has been upgraded to a Zacks Rank #2 (Buy), showing optimism for its future performance.Investors are advised to monitor company developments, earnings reports, and industry trends that could affect Crown Holdings' stock price and analysts' price targets.Crown Holdings, Inc. (NYSE:CCK) is a well-establish ...

Core Viewpoint - Analysts project O'Reilly Automotive (ORLY) will report quarterly earnings of $0.83 per share, a 9.2% increase year over year, with revenues expected to reach $4.7 billion, up 7.6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.4% in the past 30 days, reflecting a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Estimates - Sales to Do-It-Yourself Customers are expected to reach $2.37 billion, indicating a 6.8% increase from the prior year [5]. - Other sales and sales adjustments are projected at $119.61 million, reflecting a 2.7% increase year over year [5]. - Sales to professional service provider customers are estimated at $2.22 billion, suggesting a 9.5% year-over-year change [5]. Store and Square Footage Estimates - Total square footage is expected to be 50 million square feet, up from 48 million square feet in the same quarter last year [6]. - The total number of stores is projected to reach 6,534, compared to 6,291 a year ago [6]. - The ending domestic store count is anticipated to be 6,402, an increase from 6,187 in the same quarter last year [6]. Additional Store Metrics - The number of stores opened is likely to be 47, consistent with the previous year's figure [7]. - The ending Canada store count is expected to remain at 26, unchanged from the prior year [7]. - Domestic new stores opened are projected at 40, up from 35 a year ago [8]. - Mexico stores at the end of the period are estimated at 107, compared to 78 last year [8]. - Sales per weighted-average square foot are expected to reach $93.73 million, up from $89.17 million year over year [8]. Overall Performance - O'Reilly Automotive shares have shown a return of -2.4% over the past month, while the Zacks S&P 500 composite has increased by 0.7% [9]. - With a Zacks Rank 4 (Sell), ORLY is expected to underperform the overall market in the near future [9].

Core Viewpoint - Agilent Technologies is expected to report quarterly earnings of $1.37 per share, a 3.8% increase year-over-year, with revenues projected at $1.66 billion, reflecting a 5.1% year-over-year increase [1]. Financial Projections - Analysts have not revised the consensus EPS estimate for the quarter in the last 30 days, indicating stability in forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Estimates by Segment - The estimated 'Net Revenue- Life Sciences and Diagnostics Markets Segment' is $631.29 million, showing a year-over-year decrease of 19.3% [5]. - 'Net Revenue- Agilent Crosslab Group' is expected to reach $720.15 million, indicating a significant year-over-year increase of 75.2% [5]. - 'Revenue by End Markets- Chemical and advanced materials' is projected at $376.71 million, reflecting a 5.8% increase from the prior year [6]. - 'Revenue by End Markets- Environmental and Forensics' is estimated at $170.70 million, with a year-over-year change of 1.6% [6]. - 'Revenue by End Markets- Diagnostics and Clinical' is expected to be $249.80 million, indicating a 3.2% increase from the previous year [7]. - The consensus for 'Revenue by End Markets- Academia and Government' stands at $137.61 million, reflecting a year-over-year increase of 7.5% [7]. - 'Revenue by End Markets- Pharmaceutical' is projected at $581.31 million, indicating a year-over-year increase of 7.7% [7]. - 'Revenue by End Markets- Food' is expected to reach $150.33 million, reflecting a 4.4% increase from the prior year [8]. Stock Performance - Over the past month, Agilent shares have decreased by 2.7%, while the Zacks S&P 500 composite has increased by 1.1% [8]. - Agilent holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the upcoming period [8].

Core Insights - Analysts project The Cooper Companies (COO) will report quarterly earnings of $1.06 per share, a 10.4% increase year over year, with revenues expected to reach $1.07 billion, reflecting a 6.2% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1][2] Revenue Estimates - Revenue by Category - CVI is forecasted to reach $723.97 million, indicating a year-over-year change of +7.2% [4] - Revenue by Category - CSI is expected to be $343.37 million, suggesting a change of +4.9% year over year [4] - Revenue by Category - CSI - Office and surgical is projected at $209.17 million, reflecting a +5.7% change from the prior-year quarter [4] - Revenue by Category - CSI - Fertility is estimated at $134.62 million, indicating a +4.1% change from the year-ago quarter [5] - Revenue by Category - CVI - Sphere, other is predicted to be $371.00 million, showing a +6.2% change from the year-ago quarter [5] - Revenue by Category - CVI - Toric and multifocal is expected to reach $352.82 million, indicating an +8.1% change from the prior-year quarter [6] Geographic Revenue Estimates - Revenue by Geography - Americas is projected at $311.49 million, reflecting a +11.3% change from the year-ago quarter [6] - Revenue by Geography - Asia Pacific is expected to be $143.68 million, suggesting a +3.1% year-over-year change [6] - Revenue by Geography - EMEA is forecasted to reach $267.71 million, indicating a +4.4% year-over-year change [7] Stock Performance - Shares of The Cooper Companies have shown a return of -1% over the past month, compared to the Zacks S&P 500 composite's +1.1% change [7] - The company holds a Zacks Rank 3 (Hold), indicating expectations to mirror overall market performance in the near future [7]

Core Insights - Analysts project that Keysight (KEYS) will report quarterly earnings of $1.68 per share, reflecting a 7% year-over-year increase [1] - Revenue is expected to reach $1.31 billion, marking a 7.9% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.8% lower over the last 30 days, indicating a reevaluation by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and short-term stock performance [3] Revenue Projections - Revenue from the Communications Solutions Group is estimated at $917.23 million, an increase of 8.3% year over year [5] - Revenue from Commercial Communications is projected at $617.75 million, reflecting an 8% increase from the prior-year quarter [5] - Revenue from Aerospace, Defense & Government is estimated at $299.47 million, suggesting an 8.9% year-over-year increase [6] - Revenue from the Electronic Industrial Solutions Group is expected to reach $396.45 million, indicating a 7.2% increase year over year [6] Income from Operations - Income from operations for the Electronic Industrial Solutions Group is projected at $88.33 million, up from $74.00 million a year ago [7] - Income from operations for the Communications Solutions Group is expected to be $253.54 million, compared to $223.00 million in the same quarter last year [7] Stock Performance - Over the past month, Keysight shares have returned +6.2%, outperforming the Zacks S&P 500 composite's +3.5% change [8] - Keysight holds a Zacks Rank 3 (Hold), suggesting performance alignment with the overall market in the upcoming period [8]

Core Insights - Analysts forecast Eaton (ETN) to report quarterly earnings of $2.92 per share, reflecting a year-over-year increase of 7% and revenues of $6.93 billion, which is a 9.1% increase compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating that analysts have not revised their projections during this period [2] - Revisions to earnings projections are crucial for predicting investor behavior and are strongly linked to short-term stock price performance [3] Key Metrics Forecast - Estimated 'Net Sales- eMobility' is projected at $191.13 million, showing a year-over-year change of +1.1% [5] - 'Net Sales- Aerospace' is expected to reach $1.03 billion, indicating a +7.9% change from the prior year [5] - 'Net Sales- Vehicle' is forecasted at $674.75 million, reflecting a -6.7% change from the previous year [5] - 'Net Sales- Electrical Global' is anticipated to be $1.70 billion, with a +5.9% year-over-year change [6] - 'Net Sales- Electrical Americas' is projected to reach $3.31 billion, indicating a +15.2% change [6] Segment Operating Profit Estimates - 'Segment operating profit (loss)- Aerospace' is expected to be $239.31 million, up from $206.00 million in the same quarter last year [6] - 'Segment operating profit (loss)- Vehicle' is forecasted at $108.81 million, down from $130.00 million in the same quarter last year [7] - 'Segment operating profit (loss)- Electrical Global' is projected to be $327.71 million, compared to $305.00 million in the same quarter last year [7] - 'Segment operating profit (loss)- Electrical Americas' is expected to reach $975.36 million, up from $859.00 million in the previous year [8] Stock Performance - Over the past month, Eaton shares have returned +8.9%, outperforming the Zacks S&P 500 composite's +2.7% change [8] - Currently, ETN holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]

Core Viewpoint - Analysts forecast a significant decline in Biogen Inc.'s quarterly earnings and revenues, indicating potential challenges for the company in the upcoming earnings release [1][2]. Financial Performance Estimates - Expected earnings per share (EPS) for Biogen is $3.94, reflecting a year-over-year decline of 25.4% [1]. - Anticipated revenues are projected at $2.32 billion, which is a decrease of 5.8% compared to the same quarter last year [1]. Revisions and Trends - Over the past 30 days, the consensus EPS estimate has been revised downward by 2.7%, indicating a shift in analysts' expectations [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3]. Product Revenue Estimates - Revenue from the product TYSABRI for Multiple Sclerosis is estimated at $372.66 million, down 19.4% year-over-year [5]. - Revenue from SPINRAZA for Rare Disease is projected at $396.92 million, indicating a decline of 7.5% year-over-year [5]. - SKYCLARYS for Rare Disease is expected to generate $128.37 million, showing a year-over-year increase of 28.4% [5]. Detailed Product Revenue Breakdown - Total net product revenue is estimated to be $1.72 billion, reflecting a year-over-year decrease of 9.5% [6]. - TYSABRI revenue in the United States is projected at $203.91 million, down 18% year-over-year [6]. - Revenue from TECFIDERA in the United States is expected to be $32.02 million, indicating a decline of 27.4% year-over-year [7]. Additional Revenue Insights - SPINRAZA revenue from the Rest of World is estimated at $244.01 million, down 10.2% from the previous year [8]. - Revenue from SPINRAZA in the United States is projected at $156.29 million, showing a slight decline of 0.6% year-over-year [8]. - Revenue from Interferon products in the United States is expected to be $129.57 million, reflecting a decrease of 10.9% year-over-year [9]. Stock Performance - Over the past month, Biogen's shares have decreased by 1.7%, contrasting with a 3.4% increase in the Zacks S&P 500 composite [10]. - Biogen currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [10].

Core Viewpoint - Analysts project Snap-On (SNA) will report quarterly earnings of $4.61 per share, a decline of 6.1% year over year, with revenues expected to reach $1.15 billion, down 2.2% from the same quarter last year [1] Earnings Estimates - There has been no revision in the consensus EPS estimate for the quarter over the last 30 days, indicating analysts' collective reconsideration of their initial forecasts [1][2] - Changes in earnings estimates are crucial for predicting investor reactions to the stock [2] Key Metrics Projections - Analysts estimate 'Net Sales- Repair Systems & Information Group' will reach $469.57 million, reflecting a year-over-year increase of 3.3% [4] - 'Net Sales- Snap-on Tools Group' is expected to be $467.58 million, indicating a decline of 3% year over year [4] - 'Net Sales- Commercial & Industrial Group' is projected at $359.03 million, down 3.5% year over year [4] Operating Earnings Forecast - 'Operating earnings / (losses)- Financial services' is expected to be $68.73 million, compared to $70.20 million from the previous year [5] - 'Operating earnings / (losses)- Commercial & Industrial Group' is forecasted at $57.86 million, down from $62.20 million year over year [5] - 'Operating earnings / (losses)- Snap-on Tools Group' is projected at $107.02 million, compared to $114.80 million in the same quarter last year [6] - 'Operating earnings / (losses)- Repair Systems & Information Group' is expected to be $112.74 million, slightly down from $113.60 million year over year [6] Stock Performance - Over the past month, Snap-On shares have returned +2.4%, while the Zacks S&P 500 composite has changed +4% [7] - Snap-On currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7]

Core Insights - Analysts project Hilton Worldwide Holdings Inc. (HLT) will report quarterly earnings of $1.61 per share, reflecting a year-over-year increase of 5.2% [1] - Revenue is expected to reach $2.71 billion, also representing a 5.2% increase from the same quarter last year [1] Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted upward by 0.1%, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Breakdown - Analysts estimate 'Revenues- Other revenues from managed and franchised properties' at $1.61 billion, a 5.8% increase year-over-year [5] - 'Revenues- Owned and leased hotels' are projected at $258.21 million, indicating a 1.3% increase from the prior year [5] - 'Revenues- Other revenues' are expected to reach $55.03 million, reflecting a 10.1% increase year-over-year [6] - 'Revenues- Franchise and licensing fees' are forecasted at $629.00 million, suggesting a 10.2% increase [6] - 'Revenues- Incentive management fees' are estimated at $67.81 million, showing a year-over-year decrease of 3.1% [7] - 'Revenues- Base and other management fees' are projected at $88.41 million, indicating a significant decline of 16.6% from the previous year [7] Property Metrics - Total Owned / Leased Rooms are projected to be 17,109, down from 17,492 in the same quarter last year [8] - Revenue per available room - System-Wide is expected to reach $106.21, compared to $104.16 a year ago [8] - Total Systemwide Rooms are forecasted to be 1,273,692, up from 1,197,329 in the previous year [8] Stock Performance - Over the past month, shares of Hilton Worldwide have returned -5.5%, compared to a -4.8% change in the Zacks S&P 500 composite [9] - Currently, HLT holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [9]